{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:29:32Z","timestamp":1781018972647,"version":"3.54.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","funder":[{"DOI":"10.13039\/501100018553","name":"Science and Technology Plan Project of Wenzhou Municipality","doi-asserted-by":"crossref","award":["Y20240372"],"award-info":[{"award-number":["Y20240372"]}],"id":[{"id":"10.13039\/501100018553","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018553","name":"Science and Technology Plan Project of Wenzhou Municipality","doi-asserted-by":"crossref","award":["Y20240376"],"award-info":[{"award-number":["Y20240376"]}],"id":[{"id":"10.13039\/501100018553","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Omadacycline is a novel aminomethylcycline antibiotic that retains its antibacterial activity against strain-specific efflux pumps and ribosomal protective protein mechanisms of tetracycline resistance. To determine the concentration of omadacycline in human plasma, an ultra-high-performance liquid chromatography-tandem mass spectrometry method was developed to provide a basis for therapeutic monitoring of omadacycline in clinical settings. The experimental approach involves using an ACQUITY UPLC BEH C18 column (2.1 \u00d7 50 mm, 1.7 \u03bcm), with a mobile phase of 0.1% aqueous formic acid:acetonitrile (90:10, vol\/vol), a flow rate of 0.3 mL\u00b7min<jats:sup>\u22121<\/jats:sup>, a column temperature of 40\u00b0C, and an injection volume of 0.1 \u03bcL. Protein precipitation was employed as pretreatment, using acetonitrile as the precipitant. Minocycline was used as an internal standard. Omadacycline and internal standard were monitored in positive ion mode with the following mass transition pairs: mass\/charge (m\/z) = 557.1\u2192 470.1 for omadacycline, and m\/z = 458.3\u2192 440.9 for IS, respectively. The established method showed a good linearity in the range of 0.01\u201310 mcg\/mL of omadacycline (Y = 0.4603X + 0.0452, r<jats:sup>2<\/jats:sup> = 0.999), with the lower limit of quantification of 0.01 mcg\/mL. Method validation included accuracy, precision, matrix effect, recovery, carryover, dilution integrity, and stability, all of which met the requirements of the US Food and Drug Administration for the validation of bioanalytical methods. This method has been successfully applied to therapeutic drug monitoring in patients.<\/jats:p>","DOI":"10.1097\/ftd.0000000000001308","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T10:00:41Z","timestamp":1739354441000},"page":"587-593","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Development of a UHPLC-MS\/MS Method for the Determination of Omadacycline in Human Plasma"],"prefix":"10.1097","volume":"47","author":[{"given":"Chuang","family":"Chen","sequence":"first","affiliation":[{"name":"School of Pharmacy, Wenzhou Medical University, Wenzhou, People's Republic of China;"},{"name":"Department of Pharmacy, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Jie","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Wenzhou Medical University, Wenzhou, People's Republic of China;"},{"name":"Department of Pharmacy, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Wenzhou Medical University, Wenzhou, People's Republic of China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Lishui Central Hospital, Lishui, People's Republic of China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Ting","family":"Qin","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Wenzhou Medical University, Wenzhou, People's Republic of China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yu","family":"Kong","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Wenzhou Medical University, Wenzhou, People's Republic of China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Yang","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Wenzhou Medical University, Wenzhou, People's Republic of China;"},{"name":"Department of Pharmacy, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Hua","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Wenzhou Medical University, Wenzhou, People's Republic of China;"},{"name":"Clinical Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Ben","family":"Yu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Wenzhou Medical University, Wenzhou, People's Republic of China;"},{"name":"Department of Pharmacy, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"R1-20250912","first-page":"1","article-title":"Deaths: final data for 2014, National Vital Statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics","volume":"65","author":"Kochanek","year":"2016","journal-title":"Natl Vital Stat Syst"},{"key":"R2-20250912","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R6-20250912","doi-asserted-by":"crossref","first-page":"7044","DOI":"10.1128\/AAC.01536-15","article-title":"Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline","volume":"59","author":"Honeyman","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"R7-20250912","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2217\/fmb-2016-0100","article-title":"Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections","volume":"11","author":"Villano","year":"2016","journal-title":"Future Microbiol"},{"key":"R8-20250912","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1128\/AAC.01066-13","article-title":"Mechanism of action of the novel aminomethylcycline antibiotic omadacycline","volume":"58","author":"Draper","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-20250912","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1016\/j.bmc.2016.07.029","article-title":"Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic","volume":"24","author":"Tanaka","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"R10-20250912","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.01242-13","article-title":"In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline","volume":"58","author":"Macone","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R11-20250912","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMe1900188","article-title":"Omadacycline - the newest tetracycline","volume":"380","author":"Chambers","year":"2019","journal-title":"N Engl J Med"},{"key":"R12-20250912","doi-asserted-by":"crossref","first-page":"e02263-19","DOI":"10.1128\/AAC.02263-19","article-title":"Population pharmacokinetic analyses for omadacycline using phase 1 and 3 data","volume":"64","author":"Lakota","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"R13-20250912","doi-asserted-by":"crossref","first-page":"e01784-16","DOI":"10.1128\/AAC.01784-16","article-title":"Pharmacokinetics, distribution, metabolism, and excretion of omadacycline following a single intravenous or oral dose of 14C-omadacycline in rats","volume":"61","author":"Lin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"R14-20250912","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1080\/00498254.2016.1213465","article-title":"Clinical disposition, metabolism and in vitro drug-drug interaction properties of omadacycline","volume":"47","author":"Flarakos","year":"2017","journal-title":"Xenobiotica"},{"key":"R17-20250912","doi-asserted-by":"crossref","first-page":"107503","DOI":"10.1016\/j.vascn.2024.107503","article-title":"Development, validation, and clinical application of a UPLC-MS\/MS method for omadacycline determination in human serum","volume":"127","author":"Suhang","year":"2024","journal-title":"J Pharmacol Toxicol Methods"},{"key":"R18-20250912","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s40262-019-00843-4","article-title":"Omadacycline: a review of the clinical pharmacokinetics and pharmacodynamics","volume":"59","author":"Rodvold","year":"2020","journal-title":"Clin Pharmacokinet"},{"key":"R20-20250912","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/FTD.0000000000000473","article-title":"Comparison of the ARK immunoassay with high-performance liquid chromatography with ultraviolet detection for therapeutic drug monitoring of linezolid","volume":"40","author":"Castoldi","year":"2018","journal-title":"Ther Drug Monit"},{"key":"R21-20250912","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jchromb.2016.06.033","article-title":"Simultaneous determination and stability studies of linezolid, meropenem and vancomycin in bacterial growth medium by high-performance liquid chromatography","volume":"1028","author":"Wicha","year":"2016","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R22-20250912","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpba.2018.01.031","article-title":"Simultaneous quantification of cefepime, meropenem, ciprofloxacin, moxifloxacin, linezolid and piperacillin in human serum using an isotope-dilution HPLC-MS\/MS method","volume":"152","author":"Paal","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"R23-20250912","doi-asserted-by":"crossref","first-page":"e01487-17","DOI":"10.1128\/AAC.01487-17","article-title":"Safety and pharmacokinetics of the aminomethylcycline antibiotic omadacycline administered to healthy subjects in oral multiple-dose regimens","volume":"62","author":"Bundrant","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-20250912","doi-asserted-by":"crossref","first-page":"e02083-18","DOI":"10.1128\/AAC.02083-18","article-title":"Pharmacokinetics, safety, and clinical outcomes of omadacycline in women with cystitis: results from a phase 1b study","volume":"63","author":"Overcash","year":"2019","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T12:02:02Z","timestamp":1757678522000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001308","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"2024-09-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}